You’ll soon be faced—if you’re in general paediatrics in Europe—with a parent or adolescent asking for inhaled insulin. What will you do? There are, as we write, three randomised trials showing greater patient satisfaction and equivalent glycaemic control using inhaled instead of short acting subcutaneous insulin. The trials lasted 12 or 24 weeks. They were in adults. And there are many other non-injected insulins close to …